1.Hunter P.A., Reeves D.S. The current status of surveillance of resistance to antimicrobial agents: report on a meeting, J. Antimicrob. Chemoth. 49 (2002) 17-23.2.Finlay B.B., Hancock R.E. 2004. Can innate immunity be enhanced to treat microbial infections. Nature Rev. Microbiol. 2:497–504.3.Bechinger B. 1997. Structure and functions of channel-forming peptides: magainins, cecropins, melittin, and alamethicin. J. Membr. Biol. 156:197-2114.Lazarev V.N., Shakarupeta M.М., Kostyukova Е.S., Titova G.А., Akopian T.А., Govorun V.М. Development of approaches to gene therapy of mycoplasmosis and clamidiosis using genes of antimicrobic peptides. Molecular medicine (2005) No1, 60-64.5.Nir-Paz R., Prevost M.C., Nicolas P., Blanchard A. - Wroblewski H. (2002). Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membraneactive peptides and enrofloxacin in human tissue cell cultures. Antimicrobial Agents Chemotherapy, 46, 1218-1225.6.Beven L., Castano S., Dufourcq J., Wieslander A., Wroblewski H. (2003). The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes. European Journal of Biochemistry, 270, 2207-2217.7.Lazarev V.N., Parfenova T.M., Gularyan S.K., Misyurina O.Y., Akopian T.A. - Govorun V.M. (2002). Induced expression of melittine, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line. International Journal of Antimicrobial Agents, 19, 133-137.8.Razin S., Jacobs E. (1992). Mycoplasma adhesion. Journal of General Microbiology, 138, 407-422.